FUNCTIONAL ASPECTS OF MULTICATALYTIC PROTEINASE
FUNCTIONAL ASPECTS OF MULTICATALYTIC PROTEINASE
批准号:
2210645
负责人:
CHRISTOPHER P CARDOZO
金额:
$8.73万
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-07-01 至 1996-06-30
关键词:
SDS polyacrylamide gel electrophoresis acidity /alkalinity active sites animal tissue calcium cell growth regulation endopeptidases enzyme activity enzyme structure enzyme substrate analog high performance liquid chromatography magnesium peptide chemical synthesis polyamines protease inhibitor protein degradation protein sequence protein structure function serine proteinases sodium synthetic peptide tissue /cell culture
中文摘要
多催化蛋白酶复合物(MPC),也称为多催化蛋白酶复合物。
蛋白酶体,是一种高分子量(约700 kDa)
由28至32个低分子量亚基组成细胞内颗粒
(22 34 kDa),其中13个是不相同的。MPC的重要性
对于基本细胞功能的研究表明,
存在于所有真核细胞中,它是高度保守的
进化,它参与抗原加工,
构成了泛素依赖性途径的“蛋白水解核心”
细胞内蛋白水解,它是不可或缺的细胞
生存和增殖。MPC表达的变化
与恶性肿瘤的病理生理学有关,
在患者血清中发现了抗MPC的自身抗体
系统性红斑狼疮MPC显示出三种不同的
蛋白水解活性切割羧基侧的肽键,
碱性、酸性和疏水性氨基酸残基,它们都对
通过3,4-二氯异香豆素(DCI)(一种通用丝氨酸)灭活
蛋白酶抑制剂我们最近发现了第四种,
在支链的羧基侧上切割肽键的组分
链氨基酸,并构成了降解的主要因素,
蛋白质和天然肽。该实验室的主要目标是
确定MPC的哪些子单元和多少个子单元是
蛋白水解活性,以确定其特异性和蛋白水解
机制,以检查调节蛋白水解活性的因素
并合成特异性抑制剂,
研究复合物在细胞功能中的作用。的目的
这一建议是:1)评估的特异性和监管
第四种DCI抗性成分的活性,2)确定是否存在
最近鉴定的脯氨酰氨基肽酶样活性表达为
MPG的一种新成分,如果是这样,
和特异性,3)确定最近鉴定的脯氨酰-
内肽酶样活性是由于一种独特的组分,如果是这样,
检查其属性和特异性,4)调查
一组肽的结构要求和动力学,
激活MPC,5)在完整细胞中检查MPC的功能
通过研究特异性抑制剂对细胞内蛋白质的影响,
降解和细胞增殖。
英文摘要
The multicatalytic proteinase complex (MPC), also referred to as the
proteasome, is a high molecular mass (approximately 700 kDa)
intracellular particle composed of 28 to 32 low molecular mass subunits
(22 to 34 kDa) of which 13 are nonidentical. The importance of the MPC
for fundamental cell functions is indicated by the finding that it is
present in all eukaryotic cells, that it is highly conserved in
evolution, that it is involved in antigen processing, that it
constitutes the 'proteolytic core' of the ubiquitin-dependent pathway
for intracellular proteolysls and that it is indispensable for cell
survival and proliferation. Changes in the expression of the MPC have
been implicated in the pathophysiology of malignancies, and
autoantibodies against the MPC have been found in serum of patients
with systemic lupus erythematosus. The MPC exhibits three distinct
proteolytic activities cleaving peptide bonds on the carboxyl side of
basic, acid and hydrophobic amino acid residues, all sensitive to
inactivation by 3,4-dichloroisocoumarin (DCI), a general serine
protease inhibitor. We have recently identified a fourth, DCI resistant
component that cleaves peptide bonds on the carboxyl side of branched
chain amino acids, and constitutes a major factor in the degradation of
proteins and natural peptides. Major goals of this laboratory are to
determine which and how many of the subunits of the MPC are
proteolytically active, to identify their specificity and proteolytic
mechanism, to examine factors that regulate the proteolytic activity
and to synthesize specific inhibitors that could be used as probes in
studies on the role of the complex in cellular functions. The aims of
this proposal are: 1) to evaluate the specificity and regulation of
activity of the fourth, DCI resistant component, 2) to determine if a
recently identified prolyl aminopeptidase-like activity is expressed by
a novel component of the MPG, and if so to investigate its properties
and specificity, 3) to determine if a recently identified prolyl-
endopeptidase-like activity is due to a unique component, and if so to
examine its properties and specificity, 4) to investigate the
structural requirements and kinetics of a group of peptides that
activate the MPC, 5) to examine the function of the MPC in intact cells
by studying the effect of specific inhibitors on intracellular protein
degradation and on cell proliferation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ShEEP Request for a Multimodal Plate Reader
-
批准号:10738976
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2023
-
负责人:CHRISTOPHER P CARDOZO
-
依托单位:
Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI
-
批准号:10418624
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:CHRISTOPHER P CARDOZO
-
依托单位:
Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI
-
批准号:10664874
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:CHRISTOPHER P CARDOZO
-
依托单位:
ShEEP-IC: Jess Simple Western System
-
批准号:10176059
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:CHRISTOPHER P CARDOZO
-
依托单位:
ShEEP Request for A Metabolic and Behavioral Phenotyping System
-
批准号:9795306
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:CHRISTOPHER P CARDOZO
-
依托单位:
[ShEEP/LAMb] Request for a Seahorse Extracellular Flux Analyzer
-
批准号:9209599
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:CHRISTOPHER P CARDOZO
-
依托单位:
Notch and Wnt signaling in protection by nandrolone against disuse atrophy
-
批准号:8202501
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:CHRISTOPHER P CARDOZO
-
依托单位:
Notch and Wnt signaling in protection by nandrolone against disuse atrophy
-
批准号:8424827
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:CHRISTOPHER P CARDOZO
-
依托单位:
Notch and Wnt signaling in protection by nandrolone against disuse atrophy
-
批准号:8840070
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:CHRISTOPHER P CARDOZO
-
依托单位:
Attenuation of denervation atrophy by nandrolone: molecular mechanisms
-
批准号:7750432
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:CHRISTOPHER P CARDOZO
-
依托单位:
Attenuation of denervation atrophy by nandrolone: molecular mechanisms
-
批准号:8837614
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:CHRISTOPHER P CARDOZO
-
依托单位:
FUNCTIONAL ASPECTS OF THE MULTICATALYTIC PROTEINASE COMP
-
批准号:3083260
-
项目类别:
-
资助金额:$8.67万
-
财政年份:1993
-
负责人:CHRISTOPHER P CARDOZO
-
依托单位:
FUNCTIONAL ASPECTS OF MULTICATALYTIC PROTEINASE
-
批准号:2210646
-
项目类别:
-
资助金额:$8.74万
-
财政年份:1993
-
负责人:CHRISTOPHER P CARDOZO
-
依托单位:
CYSTEINE PROTEASE-CYSTATIN C BALANCE IN THE LUNG
-
批准号:3051498
-
项目类别:
-
资助金额:$3.53万
-
财政年份:1992
-
负责人:CHRISTOPHER P CARDOZO
-
依托单位:
CYSTEINE PROTEASE-CYSTATIN C BALANCE IN THE LUNG
-
批准号:3051497
-
项目类别:
-
资助金额:$3.53万
-
财政年份:1991
-
负责人:CHRISTOPHER P CARDOZO
-
依托单位:
CYSTEINE PROTEASE-CYSTATIN C BALANCE IN THE LUNG
-
批准号:3051496
-
项目类别:
-
资助金额:$3.45万
-
财政年份:1990
-
负责人:CHRISTOPHER P CARDOZO
-
依托单位: